News

FDA Grants Priority Review for IMAAVY (Nipocalimab-aahu) as First Potential Treatment for Warm Autoimmune Hemolytic Anemia

FDA · Autoimmune Hematology · 3 min

FDA Approves Johnson & Johnson's CAPLYTA (Lumateperone) sNDA for Schizophrenia Relapse Prevention

FDA · 2 min

Clinical Outsourcing Group: Pharma News Roundup (April 28, 2026)

general · 4 min

4th Annual COG 2026: No Major Pharma News Today

general · 4 min

Pharma Compliance Congress: Key Takeaways Day 1

regulatory · 6 min

ACRP 2026: Patient-Centric Trials & Workforce Expansion

immunology · 8 min

Pharma Compliance Congress: Key Regulatory Updates Day 1

regulatory · 6 min

Testosterone Therapy FDA Update: Key Regulatory Advances

FDA · testosterone deficiency in men · 3 min

GLP-1 Eating Disorder Risk: What You Need to Know

FDA · Obesity and type 2 diabetes · 4 min

AACR 2026: AI Pathology & Oncolytic Virus Spark Interest

oncology · 8 min

INTERPHEX 2026: Phillips Medisize's Embedded Sensing Tech

biotech · 8 min

Ascletis Completes Enrollment for ASC30 Oral GLP-1 Diabetes Drug Phase II Trial

3 min